Bio-Rad (BIO) Q4 Earnings Miss Estimates, Operating Margin Up
Bio-rad Laboratories Inc. | BioWorld
Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha
Leading Life Science Research & Clinical Diagnostics — Bio-Rad
Bio-Rad extends range of anti-idiotypic antibodies for bioanalysis and drug monitoring - BioTechniques
Bio-Rad's CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing - Clinical Laboratory int.
Bio-Rad Launches the SEQuoia RiboDepletion Kit for Next-Generation Sequencing
Bio-Rad Laboratories, Inc. Company Profile: Financials, Valuation, and Growth | PrivCo